<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>AMPICILLIN- ampicillin trihydrate capsule </strong><br>A-S Medication Solutions LLC<br></p></div>
<h1><span class="Bold">AMPICILLIN CAPSULES, USP 250 mg and 500 mg<br>AMPICILLIN FOR ORAL SUSPENSION, USP 125 mg/5 mL and 250 mg/5 mL<br>Rx Only</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ampicillin capsules, Ampicillin for Oral Suspension and other antibacterial drugs, Ampicillin Capsules and Ampicillin for Oral Suspension should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Ampicillin trihydrate is a semisynthetic penicillin derived from the basic penicillin nucleus, 6-aminopenicillanic acid. Ampicillin is designated chemically as (2S, 5R, 6R)-6-[(R)-2-Amino-2-phenylacetamido]-3, 3-dimethyl-7-oxo-4-thia-l-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate. </p>
<p>It has the following chemical structure:</p>
<div class="Figure">
<a name="id-925341841"></a><img alt="Ampicillin trihydrate Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=be35570c-239f-4320-bbcd-58971810943f&amp;name=1422ac93-067c-489b-9b95-17cd00303f4c-01.jpg">
</div>
<p>The molecular formula is C<span class="Sub">16</span>H<span class="Sub">19</span>N<span class="Sub">3</span>O<span class="Sub">4</span>S.3H<span class="Sub">2</span>O, and the molecular weight is 403.45.</p>
<p>Ampicillin Capsules, USP for oral administration provide ampicillin trihydrate equivalent to 250 mg and 500 mg ampicillin. Ampicillin Capsules, USP also contains magnesium stearate, NF. The capsule shell contains black iron oxide; D&amp;C red No. 28; FD&amp;C blue No. 1; gelatin, NF; silicon dioxide, NF; sodium lauryl sulfate, NF; titanium dioxide USP.</p>
<p>Ampicillin for Oral Suspension, USP provides ampicillin trihydrate equivalent to 125 mg/5 mL and 250 mg/5 mL ampicillin. Ampicillin for Oral Suspension, USP also contains flavors; microcrystalline cellulose and carboxymethylcellulose sodium, NF; colloidal silicon dioxide, NF; sodium citrate, USP; sodium propionate, NF; sucrose, NF</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Ampicillin is bactericidal at low concentrations and is clinically effective not only against the gram-positive organisms usually susceptible to penicillin G but also against a variety of gram-negative organisms. It is stable in the presence of gastric acid and is well absorbed from the gastrointestinal tract. It diffuses readily into most body tissues and fluids; however, penetration into the cerebrospinal fluid and brain occurs only with meningeal <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span>. Ampicillin is excreted largely unchanged in the urine; its excretion can be delayed by concurrent administration of probenecid which inhibits the renal tubular secretion of ampicillin. In blood serum, ampicillin is the least bound of all the penicillins; an average of about 20 percent of the drug is bound to the plasma proteins as compared to 60 to 90 percent of the other penicillins. The administration of 500 mg dose of ampicillin trihydrate capsules results in an average peak blood serum level of approximately 3.0 mcg/mL; the average peak serum level for a 250 mg dose of ampicillin trihydrate for oral suspension is approximately 2.3 mcg/mL. </p>
<p>Microbiology: While <span class="Italics">in vitro</span> studies have demonstrated the susceptibility of most <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following organisms, clinical efficacy for <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> other than those included in the <a href="#ID_1a6af915-5159-40d7-a2c7-356860060330">INDICATIONS AND USAGE</a> section has not been documented. </p>
<p>GRAM-POSITIVE - <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of alpha- and beta-hemolytic streptococci, <span class="Italics">Streptococcus </span><span class="Italics">pneumoniae</span>, those <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of staphylococci, which do not produce penicillinase, <span class="Italics">Clostridium sp., Bacillus </span><span class="Italics">anthracis</span><span class="Italics">, </span><span class="Italics">Corynebacterium</span><span class="Italics"></span><span class="Italics"> xerose</span>, and most <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of enteracocci. </p>
<p>GRAM-NEGATIVE – <span class="Italics">Hemophilus</span><span class="Italics"></span><span class="Italics"> influenzae</span><span class="Italics">; Neisseria </span><span class="Italics">gonorrhoeae</span> and <span class="Italics">N. </span><span class="Italics">Meningitidis</span><span class="Italics">, Proteus mirabilis</span> and many <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics"><span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span></span> (including <span class="Italics">S. </span><span class="Italics">typhosa</span>), <span class="Italics">Shigella</span> and <span class="Italics">Escherichia coli.</span></p>
<p>NOTE: Ampicillin is inactivated by penicillinase and therefore is ineffective against penicillinase-producing organisms including certain <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> at staphylococci, <span class="Italics">Pseudomonas </span><span class="Italics">aeruginosa</span>, <span class="Italics">P. vulgaris, </span><span class="Italics">Klebsiella</span><span class="Italics"></span><span class="Italics"> pneumoniae</span><span class="Italics">, </span><span class="Italics">Enterobacter</span><span class="Italics"></span><span class="Italics"> aerogenes</span>, and some <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of <span class="Italics">E. coli</span>. Ampicillin is not active against Rickettsia, Mycoplasma, and "large viruses" (Miyagawanella). </p>
<p>TESTING FOR SUSCEPTIBILITY: The invading organism should be cultured and its susceptibility demonstrated as a guide to therapy. If the Kirby-Bauer method of disc susceptibility is used, a 10 mcg ampicillin disc should be used to determine the relative <span class="Italics">in vitro</span> susceptibility. </p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ampicillin capsules, Ampicillin for Oral Suspension and other antibacterial drugs, Ampicillin capsules and Ampicillin for Oral Suspension should be used only to treat or prevent <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> that are proven or strongly suspected to be caused by bacteria.  When culture and susceptibility information are available, they should be considered in selecting of modifying anitimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy.</p>
<p>Ampicillin capsules and Ampicillin for oral suspension are indicated in the treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the designated organisms listed below: </p>
<p><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> of the genitourinary tract including <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> - <span class="Italics">E. coli, P. mirabilis</span>, enterococci, <span class="Italics">Shigella</span><span class="Italics">, S. </span><span class="Italics">typhosa</span> and other <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span> and nonpenicillinase-producing <span class="Italics">N. </span><span class="Italics">gonorrhoeae</span>. </p>
<p><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> of the respiratory tract - Nonpenicillinase-producing <span class="Italics">H. </span><span class="Italics">influenzae</span> and staphylococci, and streptococci including <span class="Italics">Streptococcus </span><span class="Italics">pneumoniae</span>. </p>
<p><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infections</span> of the gastrointestinal tract -<span class="Italics"></span><span class="Italics">Shigella</span><span class="Italics">, S. </span><span class="Italics">typhosa</span> and other <span class="Italics"><span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span>, E. coli, P. mirabilis</span>, and enterococci. </p>
<p><span class="product-label-link" type="condition" conceptid="435785" conceptname="Meningitis">Meningitis</span> - <span class="Italics">N. </span><span class="Italics">Meningitidis</span></p>
<p>Bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed. Therapy may be instituted prior to the results of susceptibility testing.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">A history of a previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> to any of the penicillins is a contraindication. Ampicillin is also contraindicated in <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by penicillinase-producing organisms.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">SERIOUS AND OCCASIONALLY FATAL <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY</span> (ANAPHYLACTOID) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. ALTHOUGH <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">ANAPHYLAXIS</span> IS MORE FREQUENT FOLLOWING PARENTERAL THERAPY, IT HAS OCCURRED IN PATIENTS ON ORAL PENICILLINS. THESE REACTIONS ARE MORE LIKELY TO OCCUR IN INDIVIDUALS WITH A HISTORY OF SENSITIVITY TO MULTIPLE ALLERGENS. THERE HAVE BEEN REPORTS OF INDIVIDUALS WITH A HISTORY OF PENICILLIN <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY</span> WHO HAVE EXPERIENCED SEVERE REACTIONS WHEN TREATED WITH CEPHALOSPORINS. BEFORE THERAPY WITH ANY PENICILLIN, CAREFUL INQUIRY SHOULD BE MADE CONCERNING PREVIOUS <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">HYPERSENSITIVITY REACTIONS</span> TO PENICILLINS, CEPHALOSPORINS, OR OTHER ALLERGENS. IF AN <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">ALLERGIC REACTION</span> OCCURS, APPROPRIATE THERAPY SHOULD BE CONSIDERED. <span class="Bold">SERIOUS <span class="product-label-link" type="condition" conceptid="4148381" conceptname="Anaphylactoid reaction">ANAPHYLACTOID REACTIONS</span> REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE. OXYGEN, INTRAVENOUS STEROIDS, AND AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINISTERED AS INDICATED. </span></p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">Pseudomembranous colitis</span> has been reported with nearly all antibacterial agents, including ampicillin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> subsequent to the administration of antibacterial agents. </span></p>
<p>Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by <span class="Italics">Clostridium </span><span class="Italics">difficile</span> is a primary cause of "antibiotic-associated <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>". </p>
<p>After the diagnosis of <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span> has been established, therapeutic measures should be initiated. Mild cases of <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span> usually respond to discontinuation of the drug alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation, and treatment with an antibacterial drug clinically effective against<span class="Italics"> C. </span><span class="Italics">difficile</span> <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Prescribing Ampicillin capsules and Ampicillin for Oral Suspension in the absence of a proven or strongly suspected <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span> of a <span class="product-label-link" type="condition" conceptid="4118659" conceptname="Prophylactic">prophylactic</span> indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria. </p>
<p>Prolonged use of antibiotics may promote the overgrowth of nonsusceptible organisms, including fungi. <br>Should <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occur, appropriate measures should be taken. <br>Patients with <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> who also have <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> should be given additional appropriate parenteral penicillin treatment. <br>Treatment with ampicillin does not preclude the need for surgical procedures, particularly in <span class="product-label-link" type="condition" conceptid="435459" conceptname="Staphylococcal infectious disease">staphylococcal infections</span>.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2>Information for the patient</h2>
<dl>
<dt>1.</dt>
<dd>The patient should inform the physician of any history of sensitivity to allergens, including previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> to penicillins and cephalosporins (see <a href="#ID_be5997ed-cb07-4a14-afd2-16f5eb773512">WARNINGS</a>). </dd>
<dt>2.</dt>
<dd>The patient should discontinue ampicillin and contact the physician immediately if any side effect occurs (see <a href="#ID_be5997ed-cb07-4a14-afd2-16f5eb773512">WARNINGS</a>). </dd>
<dt>3.</dt>
<dd>Ampicillin should be taken with a full glass (8 oz) of water, one-half hour before or two hours after meals. </dd>
<dt>4.</dt>
<dd>Diabetic patients should consult with the physician before changing diet or dosage of <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> medication (see <a href="#ID_72cadb9b-fd81-4495-af5e-3dd5d98e5855">PRECAUTIONS</a>, <a href="#ID_7831c4a5-da80-4398-8717-560b514d386a">Drug/Laboratory Test Interactions</a>). </dd>
</dl>
<p class="First">Patients should be counseled that antibacterial drugs, including Ampicillin capsules and Ampicillin for Oral Suspension should only be used to treat <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>. They do not treat <span class="product-label-link" type="condition" conceptid="440029" conceptname="Viral disease">viral infections</span> (e.g. the <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">common cold</span>). </p>
<p>When Ampicilin capsules or Ampicillin for Oral Suspension are prescribed to treat a <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infection</span>, patients should be told that, although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may:</p>
<p>(i) Decrease the effectiveness of the immediate treatment, and</p>
<p>(ii) Increase the likelihood that bacteria will develop resistance and will not be treatable by Ampicillin capsules and Ampicillin for Oral Suspension or other antibacterial drugs in the future</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-7.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">In prolonged therapy, and particularly with high dosage regimens, periodic evaluation of the renal, hepatic and hematopoietic systems is recommended. In <span class="product-label-link" type="condition" conceptid="437779" conceptname="Streptococcal infectious disease">streptococcal infections</span>, therapy must be sufficient to eliminate the organism (10 days minimum); otherwise the sequelae of streptococcal disease may occur. Cultures should be taken following completion of treatment to determine whether streptococci have been eradicated. Cases of gonococcal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> with a suspected lesion of <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> should have darkfield examinations ruling out <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> before receiving ampicillin. Patients who do not have suspected lesions of <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> and are treated with ampicillin should have a follow-up serologic test for <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> each month for four months to detect <span class="product-label-link" type="condition" conceptid="436033" conceptname="Syphilis">syphilis</span> that may have been masked from treatment for <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span>. </p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">When administered concurrently, the following drugs may interact with ampicillin:</p>
<p>Allopurinol - Increased possibility of <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>; particularly in hyperuricemic patients may occur. </p>
<p>Bacteriostatic antibiotics - Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins. This has been demonstrated <span class="Italics">in vitro</span>; however, the clinical significance of this interaction is not well-documented. </p>
<p>Oral contraceptives - May be less effective and increased breakthrough <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> may occur. </p>
<p>Probenecid - May decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or ampicillin toxicity. </p>
</div>
<div class="Section" data-sectionCode="34074-5">
<a name="section-7.5"></a><p></p>
<h2>Drug/Laboratory Test Interactions</h2>
<p class="First">After treatment with ampicillin, a false-positive reaction for glucose in the urine may occur with copper sulfate tests (Benedict's solution, Fehling's solution, or Clinitest® tablets) but not with enzyme based tests such as Clinistix® and Tes-Tape® (Glucose Enzymatic Test Strip USP). </p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.6"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been performed to evaluate carcinogenesis, mutagenesis, or impairment of fertility in males or females.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.7"></a><p></p>
<h2>Pregnancy</h2>
<p class="First">Teratogenic Effects</p>
<p><span class="Bold"><span class="Italics">Category B: </span></span></p>
<p>Reproduction studies in animals have revealed no evidence of impaired fertility or harm to the fetus due to penicillin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, penicillin should be used during pregnancy only if clearly needed. </p>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="section-7.8"></a><p></p>
<h2>Labor and Delivery</h2>
<p class="First">Oral ampicillin-class antibiotics are poorly absorbed during labor. Studies in guinea pigs showed that intravenous administration of ampicillin slightly decreased the uterine tone and frequency of contractions, but moderately increased the height and duration of contractions. However, it is not known whether use of these drugs in humans during labor or delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of the newborn will be necessary.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.9"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">Ampicillin-class antibiotics are excreted in milk. Ampicillin used by nursing mothers may lead to sensitization of infants; therefore, a decision should be made whether to discontinue nursing or to discontinue ampicillin, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.10"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Penicillins are excreted primarily unchanged by the kidney; therefore, the incompletely developed renal function in neonates and young infants will delay the excretion of penicillin. Administration to neonates and young infants should be limited to the lowest dosage compatible with an effective therapeutic regime (see <a href="#ID_51fd328a-e680-421e-b06c-582e61612996">DOSAGE AND ADMINISTRATION</a>). </p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are more likely to occur in individuals who have previously demonstrated <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to penicillin and in those with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span>, <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="256439" conceptname="Allergic rhinitis due to pollen">hay fever</span> or <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>. </p>
<p>The following adverse reactions have been reported as associated with the use of ampicillin: </p>
<p>Gastrointestinal: <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="138455" conceptname="Stomatitis">stomatitis</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4184503" conceptname="Enterocolitis">enterocolitis</span>, <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span>, and <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>. These reactions are usually associated with oral dosage forms of the drug. </p>
<p><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity Reactions</span>: An erythematous, mildly pruritic, maculopapular <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span> has been reported fairly frequently. The <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, which usually does not develop within the first week of therapy, may cover the entire body including the soles, palms, and oral mucosa. The <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">eruption</span> usually disappears in three to seven days. Other <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span> that have been reported are: <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rash</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="132702" conceptname="Erythema multiforme">erythema multiforme</span>, and an occasional case of <span class="product-label-link" type="condition" conceptid="4270887" conceptname="Erythroderma">exfoliative dermatitis</span>. <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylaxis</span> is the most serious reaction experienced and has usually been associated with the parenteral dosage form of the drug.</p>
<p>NOTE: <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, other <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">skin rashes</span>, and <span class="product-label-link" type="condition" conceptid="432522" conceptname="Transfusion reaction due to serum protein reaction">serum sickness</span>-like reactions may be controlled by antihistamines, and, if necessary, systemic corticosteroids. Whenever such reactions occur, ampicillin should be discontinued unless, in the opinion of the physician, the condition being treated is life-threatening and amenable only to ampicillin therapy. Serious <span class="product-label-link" type="condition" conceptid="4148381" conceptname="Anaphylactoid reaction">anaphylactoid reactions</span> require emergency measures (see <a href="#ID_86ab15ca-093d-4052-be98-4157b7c3a573">WARNINGS</a>). </p>
<p>Liver: Moderate elevation in serum glutamic oxaloacetic transaminase (<span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span>) has been noted, but the significance of this finding is unknown. </p>
<p>Hemic and Lymphatic Systems: <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="4119134" conceptname="Thrombocytopenic purpura">thrombocytopenic purpura</span>, <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>, <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, and agranulacytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> phenomena. </p>
<p>Other adverse reactions that have been reported with the use of ampicillin are laryngeal <span class="product-label-link" type="condition" conceptid="253321" conceptname="Stridor">stridor</span> and high <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>. An occasional patient may complain of <span class="product-label-link" type="condition" conceptid="4012068" conceptname="Sore mouth">sore mouth</span> or tongue as with any oral penicillin preparation.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">In case of overdosage, discontinue medication, treat symptomatically and institute supportive measures as required. In patients with renal function impairment, ampicillin-class antibiotics can be removed by hemodialysis but not by peritoneal dialysis.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Adults and children weighing over 20 Kg: <span class="Bold">For genitourinary or gastrointestinal tract <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> other than <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> in men and women</span>, the usual dose is 500 mg q.i.d. in equally spaced doses; severe or chronic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> may require larger doses. For the treatment of <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> in both men and women, a single oral dose of 3.5 grams of ampicillin administered simultaneously with 1 gram of probenecid is recommended. Physicians are cautioned to use no less than the above recommended dosage for the treatment of <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span>. Follow-up cultures should be obtained from the original site(s) of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> 7 to 14 days after therapy. In women, it is also desirable to obtain culture test-of-cure from both the endocervical and anal canals. Prolonged intensive therapy is needed for complications such as <span class="product-label-link" type="condition" conceptid="194997" conceptname="Prostatitis">prostatitis</span> and <span class="product-label-link" type="condition" conceptid="4150043" conceptname="Epididymitis">epididymitis</span>. <span class="Bold">For <span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">respiratory tract infections</span></span>, the usual dose is 250 mg q.i.d. in equally spaced doses. </p>
<p>Pediatric Patients weighing 20 Kg or less:<span class="Bold"> For genitourinary or gastrointestinal tract <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span></span>, the usual dose is 100 mg/kg/day total, q.i.d. in equally divided and spaced doses. </p>
<p><span class="Bold">For <span class="product-label-link" type="condition" conceptid="4170143" conceptname="Respiratory tract infection">respiratory tract infections</span></span>, the usual dose is 50 mg/kg/day total, in equally divided and spaced doses three to four times daily. Doses for children should not exceed doses recommended for adults.</p>
<p>All patients, irrespective of age and weight: Larger doses may be required for severe or chronic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>. Although ampicillin is resistant to degradation by gastric acid, it should be administered at least one half-hour before or two hours after meals for maximal absorption. Except for the single dose regimen for <span class="product-label-link" type="condition" conceptid="433417" conceptname="Gonorrhea">gonorrhea</span> referred to above, therapy should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or evidence at bacterial eradication has been obtained. In <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by haemolytic <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of streptococci, a minimum of 10 days' treatment is recommended to guard against the risk of <span class="product-label-link" type="condition" conceptid="442313" conceptname="Rheumatic fever">rheumatic fever</span> or <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">glomerulonephritis</span> (see <a href="#ID_72cadb9b-fd81-4495-af5e-3dd5d98e5855">PRECAUTIONS</a>, <a href="#ID_1a5c4b10-d384-4b34-a9ed-0b1333cedfb8">Laboratory Tests</a>). In the treatment of chronic urinary or gastrointestinal <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>, frequent bacteriologic and clinical appraisal is necessary during therapy and may be necessary for several months afterwards. Stubborn <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> may require treatment for several weeks. Smaller doses than those indicated above should not be used. </p>
<p><span class="Bold">Directions for mixing Oral Suspension</span></p>
<p>Prepare suspension at time of dispensing. For ease of preparation, add water to the bottle in two portions and shake well after each addition.</p>
<p>125 mg/5 mL<br>Add a total of 86 mL to the 100 mL package and 170 mL to the 200 mL package. This will provide 100 mL and 200 mL of suspension. Each 5 mL (teaspoonful) will contain ampicillin trihydrate equivalent to 125 mg ampicillin.</p>
<p>250 mg/5 mL<br>Add a total of 70 mL to the 100 mL package and 139 mL to the 200 mL package. This will provide 100 mL and 200 mL of suspension . Each 5 mL (teaspoonful) will contain ampicillin trihydrate equivalent to 250 mg ampicillin.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><span class="Bold">Ampicillin Capsules, USP 250 mg</span>: Each capsule contains ampicillin trihydrate equivalent to 250 mg ampicillin. The number 2 size capsule has a gray opaque body with a light blue opaque cap, printed WC402. </p>
<p>Bottles of 100 NDC 67253-180-10<br>Bottles of 500 NDC 67253-180-50</p>
<p><span class="Bold">Ampicillin Capsules, USP 500 mg</span>: Each capsule contains ampicillin trihydrate equivalent to 500 mg ampicillin. The number 0 size capsule has a gray opaque body with a light blue opaque cap, printed WC404. </p>
<p>Bottles of 100 NDC 67253-181-10<br>Bottles of 500 NDC 67253-181-50</p>
<p>Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].</p>
<p>Ampicillin for Oral Suspension, USP is available as a powder which when reconstituted as directed yields a white, bubble gum flavoured suspension.</p>
<p><span class="Bold">Ampicillin for Oral Suspension, USP 125 mg/5 mL:</span> Each 5 mL of reconstituted suspension contains ampicillin trihydrate equivalent to 125 mg ampicillin.</p>
<p>100 mL bottles NDC 67253-182-10<br>200 mL bottles NDC 67253-182-20</p>
<p><span class="Bold">Ampicillin for Oral Suspension, USP 250 mg/5 mL</span>: Each 5 mL of reconstituted suspension contains ampicillin trihydrate equivalent to 250 mg ampicillin.</p>
<p>100 mL bottles NDC 67253-183-10<br>200 mL bottles NDC 67253-183-20</p>
<p>Store dry powder at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].</p>
<p>Store the reconstituted suspension in a refrigerator. Discard any unused portion after 14 days.</p>
<p>Manufactured for: <span class="Bold">DAVA Pharmaceuticals, Inc</span><span class="Bold">.</span><br>Fort Lee, NJ 07024, USA</p>
<p>by: <span class="Bold">STADA Production Ireland Ltd.</span><br>Clonmel, Ireland.</p>
<p>Rev. 01/11</p>
<p>181G451</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First"><span class="Bold">NDC 54569-2411-1</span></p>
<p>Relabeled by:<br><span class="Bold">A-S Medication Solutions</span><br>Libertyville, IL 60048</p>
<br><div class="Figure"><img alt="2411-1.jpg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=be35570c-239f-4320-bbcd-58971810943f&amp;name=2411-1.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>AMPICILLIN 		
					</strong><br><span class="contentTableReg">ampicillin capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:54569-2411(NDC:67253-181)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>AMPICILLIN TRIHYDRATE</strong> (AMPICILLIN) </td>
<td class="formItem">AMPICILLIN</td>
<td class="formItem">500 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FERROSOFERRIC OXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GELATIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C RED NO. 28</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C BLUE NO. 1</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">GRAY (BLUE/GRAY) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">23mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">WC404</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:54569-2411-1</td>
<td class="formItem">28  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA062882</td>
<td class="formItem">02/25/1988</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>A-S Medication Solutions LLC
							(830016429)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">A-S Medication Solutions LLC</td>
<td class="formItem"></td>
<td class="formItem">830016429</td>
<td class="formItem">repack(54569-2411)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 6/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>5425a7ce-4cba-48dd-92cd-2c52d155546b</div>
<div>Set id: be35570c-239f-4320-bbcd-58971810943f</div>
<div>Version: 1</div>
<div>Effective Time: 20130620</div>
</div>
</div> <div class="DistributorName">A-S Medication Solutions LLC</div></p>
</body></html>
